The Broad Institute: Applying the Power of Genomics to Medicine Case Solution

In June 2003, Harvard University and MIT announced an unprecedented partnership to create a biomedical institute, the Broad Institute. The culture of comprehensive science-centered, and the people involved felt it was really scientific frontier. In just four years, the broad has made many significant scientific contributions in the biomedical field. These include understanding the genetic alterations in cancer, building RNAi Consortium to better understand the role of each gene in the human body, creating an integrated database that traced the connections between drugs, genes and diseases, and cataloging inherited genetic variations with type 2 diabetes. Opportunities for significant additional scientific progress beckons, but should funding and physical space. The leaders of the Broad Institute, including Altshuler, Director of Medicine and population genetics, and Golub, director of the Cancer Program, necessary to decide the size was too big. How many large projects could support productive? What happened when the broad overcome their physical space? Altshuler and Golub Ancha knew had made tremendous progress in the last year. He downplayed the obstacles and has attracted many young scientists who looked as big as an interesting place to do research. This success is the question of how to balance the priorities of growth and preservation of the culture that had done everything possible, even more important.
Vicki L. Sato,
Rachel Gordon
Source: Harvard Business School
32 pages.
Release Date: March 5, 2008. Prod #: 608114-PDF-ENG
The Broad Institute: Applying the power of genomics to solving medical cases

The Broad Institute: Applying the Power of Genomics to Medicine Case Solution
Share This